01 3GLAXO GRP LTD
02 2GLAXOSMITHKLINE
01 58746242
01 5Blank
01 5Y
01 52030-10-11
Patent Expiration Date : 2030-10-11
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 8746242
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-11
Patent Expiration Date : 2030-10-11
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8746242
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209482
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-11
Patent Expiration Date : 2030-10-11
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 8746242
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-11
Patent Expiration Date : 2030-10-11
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8746242
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209482
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-11
Patent Expiration Date : 2030-10-11
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 8746242
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-11
